Tasly Pharmaceutical
Tasly Pharmaceutical is a company that provides global market services with tech systems in the GMP.
Launch date
Employees
Market cap
€2.6b
Enterprise valuation
€2.2b (Public information from Sep 2024)
Share price
CNY13.9 600535.SS
Tianjin Tianjin Shi (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 13.6b | 8.0b | 8.6b | 8.7b | 9.2b | 9.8b | 10.3b |
| % growth | (29 %) | (41 %) | 8 % | 1 % | 6 % | 7 % | 5 % |
| EBITDA | 2.4b | 3.6b | 1.8b | 1.9b | 2.0b | 2.2b | 2.4b |
| % EBITDA margin | 18 % | 45 % | 21 % | 22 % | 22 % | 23 % | 23 % |
| Profit | 1.1b | 2.4b | (257m) | 1.1b | 1.2b | 1.4b | 1.5b |
| % profit margin | 8 % | 30 % | (3 %) | 12 % | 13 % | 14 % | 15 % |
| EV / revenue | 1.7x | 2.9x | 1.7x | 2.7x | 2.2x | 1.9x | 1.9x |
| EV / EBITDA | 9.6x | 6.4x | 8.4x | 12.6x | 9.8x | 8.3x | 8.0x |
| R&D budget | 689m | 580m | 844m | 917m | - | - | - |
| R&D % of revenue | 5 % | 7 % | 10 % | 11 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Tasly Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
